4.7 Article

COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction

Journal

JCI INSIGHT
Volume 6, Issue 17, Pages -

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.147472

Keywords

-

Funding

  1. NIH grant: National Heart, Lung, and Blood Institute [R00HL135265, R01HL130541, R01HL142804]
  2. NIH grant: National Institute on Aging [K01AG059892, R01AG048022, R56AG059877]
  3. NIH grant: National Institute of Neurological Disorders and Stroke grant [U24NS107228]
  4. University of Utah
  5. United States Department of Veterans Affairs Clinical Sciences R&D (CSRD) Service [I01 CX001696]

Ask authors/readers for more resources

Vascular injury in COVID-19 patients is linked to increased levels of glycosaminoglycans, particularly hyaluronan fragments and hyaluronidase activity. This damage to the glycocalyx is associated with disease severity and elevated levels of inflammatory cytokines. Pulmonary microvascular endothelial cells exposed to the COVID-19 milieu exhibit dysregulated HA biosynthesis and degradation, leading to the release of pathological HA fragments into circulation.
Vascular injury has emerged as a complication contributing to morbidity in coronavirus disease 2019 (COVID-19). The glycosaminoglycan hyaluronan (HA) is a major component of the glycocalyx, a protective layer of glycoconjugates that lines the vascular lumen and regulates key endothelial cell functions. During critical illness, as in the case of sepsis, enzymes degrade the glycocalyx, releasing fragments with pathologic activities into circulation and thereby exacerbating disease. Here, we analyzed levels of circulating glycosaminoglycans in 46 patients with COVID-19 ranging from moderate to severe clinical severity and measured activities of corresponding degradative enzymes. This report provides evidence that the glycocalyx becomes significantly damaged in patients with COVID-19 and corresponds with severity of disease. Circulating HA fragments and hyaluronidase, 2 signatures of glycocalyx injury, strongly associate with sequential organ failure assessment scores and with increased inflammatory cytokine levels in patients with COVID-19. Pulmonary microvascular endothelial cells exposed to COVID-19 milieu show dysregulated HA biosynthesis and degradation, leading to production of pathological HA fragments that are released into circulation. Finally, we show that HA fragments present at high levels in COVID-19 patient plasma can directly induce endothelial barrier dysfunction in a ROCK-and CD44-dependent manner, indicating a role for HA in the vascular pathology of COVID-19.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Platelet necrosis mediates ischemic stroke outcome in mice

Frederik Denorme, Bhanu Kanth Manne, Irina Portier, Alicia S. Eustes, Yasuhiro Kosaka, Benjamin T. Kile, Matthew T. Rondina, Robert A. Campbell

BLOOD (2020)

Article Cell Biology

Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex

Aaron C. Petrey, Fares Qeadan, Elizabeth A. Middleton, Irina V. Pinchuk, Robert A. Campbell, Ellen J. Beswick

Summary: This study aims to identify pathogenic factors linked to disease severity and patient characteristics in COVID-19 patients. 16 soluble factors were found to be increased, 2 decreased, with key factors associated with severe disease and ICU admission. Levels of IL-4 and sCD40L were higher in males, and analysis revealed associations between disease severity, sex, and biomarkers.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Article Hematology

Hyperglycemia exacerbates ischemic stroke outcome independent of platelet glucose uptake

Frederik Denorme, Irina Portier, Yasuhiro Kosaka, Robert A. Campbell

Summary: Hyperglycemia exacerbates ischemic stroke outcomes regardless of platelet glucose uptake. Additionally, hyperglycemia primes procoagulant platelet formation, highlighting the therapeutic potential of targeting procoagulant platelet formation in the treatment of acute ischemic stroke.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Hematology

Heparanase expression and activity are increased in platelets during clinical sepsis

Alicia S. Eustes, Robert A. Campbell, Elizabeth A. Middleton, Neal D. Tolley, Bhanu K. Manne, Emilie Montenont, Jesse W. Rowley, Krystin Krauel, Antoinette Blair, Li Guo, Yasuhiro Kosaka, Isabel M. Medeiros-de-Moraes, Marcus Lacerda, Eugenio D. Hottz, Hugo Castro Faria Neto, Guy A. Zimmerman, Andrew S. Weyrich, Aaron Petrey, Matthew T. Rondina

Summary: During clinical sepsis, translation and enzymatic activity of HPSE are increased in platelets. Increased expression of the active form of HPSE protein is associated with sepsis-associated mortality.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Review Hematology

Mechanisms of immunothrombosis in COVID-19

Irina Portier, Robert A. Campbell, Frederik Denorme

Summary: COVID-19 induces endotheliopathy, resulting in increased release of multimeric von Willebrand factor and potential for increased platelet adhesion. Decreased anticoagulant proteins on endothelial cells further disrupt the hemostatic balance. Dysregulation of soluble coagulation markers, platelet hyperreactivity, and cytokine storm all contribute to COVID-19 induced coagulopathy. Understanding these mechanisms can lead to future therapies for patients.

CURRENT OPINION IN HEMATOLOGY (2021)

Article Cell Biology

Human platelets display dysregulated sepsis-associated autophagy, induced by altered LC3 protein-protein interaction of the Vici-protein EPG5

Hansjorg Schwertz, Jesse W. Rowley, Irina Portier, Elizabeth A. Middleton, Neal D. Tolley, Robert A. Campbell, Alicia S. Eustes, Karin Chen, Matthew T. Rondina

Summary: Platelets play a central role in host responses during sepsis, and abnormalities in autophagic functions in platelets during sepsis are partly due to reduced EPG5-LC3 interactions, regulated by TLR4 engagement, leading to the accumulation of autophagosomes.

AUTOPHAGY (2022)

Review Hematology

Platelet Dysregulation in the Pathobiology of COVID-19

Rebecca A. Mellema, Jacob Crandell, Aaron C. Petrey

Summary: COVID-19 is increasingly recognized as a disease involving both thrombosis and inflammation, with severe cases showing hyperinflammation affecting multiple organs, especially with observations of thrombi in the vasculature. Platelets, traditionally known for their role in hemostasis, are now understood to play a crucial role in regulating immune response, which has significant implications for the pathobiology of COVID-19.

HAMOSTASEOLOGIE (2022)

Review Cell Biology

The role of hyaluronan synthesis and degradation in the critical respiratory illness COVID-19

Nansy Albtoush, Aaron C. Petrey

Summary: Hyaluronan (HA), a polysaccharide found in the extracellular matrix (ECM), plays a regulatory role in inflammation. Accumulation of HA in the airways is associated with various inflammatory diseases, including COVID-19. Critically ill COVID-19 patients frequently develop acute respiratory distress syndrome (ARDS), which is linked to the accumulation of HA in the airways.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2022)

Article Pediatrics

Neutrophil extracellular trap inhibition improves survival in neonatal mouse infectious peritonitis

Frederik Denorme, John L. Rustad, Irina Portier, Jacob L. Crandell, Claudia de Araujo, Mark J. Cody, Robert A. Campbell, Christian C. Yost

Summary: Inhibition of neutrophil extracellular traps (NETs) improves survival in experimental neonatal infectious peritonitis, suggesting the involvement of NETs in the pathogenesis of neonatal peritonitis and sepsis.

PEDIATRIC RESEARCH (2023)

Article Medicine, Research & Experimental

The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes

Frederik Denorme, Nicole D. Armstrong, Michelle L. Stoller, Irina Portier, Emilia A. Tugolukova, Rikki M. Tanner, Emilie Montenont, Seema Bhatlekar, Mark Cody, John L. Rustad, Abigail Ajanel, Neal D. Tolley, Darian C. Murray, Julie L. Boyle, Marvin T. Nieman, Steven E. Mckenzie, Christian Con Yost, Leslie A. Lange, Mary Cushman, Marguerite R. Irvin, Paul F. Bray, Robert A. Campbell

Summary: Protease-activated receptor 4 (PAR4) gene harbors a functional dimorphism associated with greater platelet aggregation, and the A allele frequency is more common in Black individuals. In this study, it was found that the A allele is associated with worse stroke outcomes and increased risk of incident ischemic stroke. Mice studies further demonstrated that mice expressing the Thr120 variant had worse stroke outcomes mediated by enhanced platelet activation and platelet-neutrophil interactions, while specific antiplatelet therapy showed improvement only in mice expressing the Ala120 variant.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Medicine, Research & Experimental

Neutrophil extracellular traps regulate ischemic stroke brain injury

Frederik Denorme, Irina Portier, John L. Rustad, Mark J. Cody, Claudia V. de Araujo, Chieko Hoki, Matthew D. Alexander, Ramesh Grandhi, Mitchell R. Dyer, Matthew D. Neal, Jennifer J. Majersik, Christian C. Yost, Robert A. Campbell

Summary: Ischemic stroke triggers a strong inflammatory response, leading to exacerbated outcomes. Neutrophil extracellular trap (NET) formation was observed in the brain tissue of ischemic stroke patients, with elevated plasma NET biomarkers correlating with worse stroke outcomes. Platelets were identified as the critical source of high-mobility group box 1 (HMGB1), which caused NETs in the acute phase of stroke. Depletion of platelets or platelet-specific knockout of HMGB1 significantly reduced plasma HMGB1 and NET levels, resulting in improved stroke outcomes. The therapeutic potential of neonatal NET-inhibitory factor (nNIF) in stroke was also investigated, with promising results in reducing brain infarcts and enhancing survival, even when administered one hour after stroke onset.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Hematology

Role of Platelets in Detection and Regulation of Infection

Irina Portier, Robert A. Campbell

Summary: Platelets, traditionally viewed as essential in hemostasis and thrombosis, have recently been recognized for their role in modulating the immune response during infectious diseases. Through the release of antimicrobial proteins upon activation, platelets can directly limit pathogen growth and aid in pathogen clearance by activating immune cells. However, abnormal platelet activation may lead to inflammation and thrombotic events.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

No Data Available